Suboptimal Adherence and LDL-C Goal Attainment With High-Intensity versus Moderate-to-Low Intensity Statins in Real-World Practice

NewAmsterdam Pharma Company NV published this content on June 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 17, 2026 at 15:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]